Cleared Traditional

K951129 - NOVATRANS II

K951129 is the FDA 510(k) clearance for NOVATRANS II by Medex, Inc.. It is a Class 2 Cardiovascular device (product code DRS) cleared through the Traditional 510(k) pathway after a 23-day FDA review.

K951129 · Medex, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1995
Decision
23d
Days
Class 2
Risk

K951129 is an FDA 510(k) clearance for the NOVATRANS II. Classified as Transducer, Blood-pressure, Extravascular (product code DRS), Class II - Special Controls.

Submitted by Medex, Inc. (Hilliard, US). The FDA issued a Cleared decision on April 5, 1995 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2850 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medex, Inc. devices

Submission Details

510(k) Number K951129 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 1995
Decision Date April 05, 1995
Days to Decision 23 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 125d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRS Transducer, Blood-pressure, Extravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRS Transducer, Blood-pressure, Extravascular

All 70
Devices cleared under the same product code (DRS) and FDA review panel - the closest regulatory comparables to K951129.
DISPOSABLE TRANSPAC III INTEGRATED TRANSDUCER (IT)
K052828 · Hospira, Inc. · Feb 2006
VIGILEO ARTERIAL PRESSURE CARDIAC OUTPUT/OXIMETRY MONITOR, MODELS MIHM1 AND MIHM1P
K043065 · Edwards Lifesciences, LLC · Jan 2005
MX960 REUSABLE PRESSURE TRANSDUCER
K961404 · Medex, Inc. · Jun 1996
COBE PATIENT MONITORING PRODUCTS
K921343 · Cobe Cardiovascular, Inc. · Jan 1993
MERITRANS(TM) DISPOSABLE TRANSDUCER
K920977 · Merit Medical Systems, Inc. · Dec 1992
SERIES 51 AND 53 DISPOSABLE PRESSURE TRANSDUCERS
K904777 · Baxter Healthcare Corp · Jan 1991